Your prediction
Pros and Cons of Alcon AG in the next few years
Pros
?
B****
?
S********** s********
?
C******** o* t** e**********
Cons
?
G***** c******* t* c**********
?
W********* I********* f** t** n*** y****
?
M***** P*******
Tell us your opinion to access the 'Wisdom of the Crowds'
News
Lineage Cell Therapeutics Maps COR1 Path With ‘Thaw and Inject’ Cell Therapy Plan
Key Points
- Interested in Lineage Cell Therapeutics, Inc.? Here are five stocks we like better.
- Lineage Cell Therapeutics outlined a manufacturing-first strategy for COR1, its preclinical
RxSight Q2 Sales Sink 20% as Alcon Deal Bolsters 2026 Outlook
Key Points
- Interested in RxSight, Inc.? Here are five stocks we like better.
- RxSight’s preliminary Q2 sales fell 20% year over year to about $27 million excluding collaboration revenue, with

